World of DTC Marketing

JUNE 1, 2021

After aducanumab showed promise in 2016, Biogen launched two late-stage trials — then stopped them halfway through, in March 2019, when an analysis concluded the studies would not reach their goal of slowing cognitive and functional impairment in participants.

FDA 187

FDA Side effects Patients Doctors 187

World of DTC Marketing

SEPTEMBER 7, 2022

According to JAMA , “in a cross-sectional study, between May 1, 2016, and May 31, 2021, there were 207 cancer drug approvals in oncology and malignant hematology. This leads to a question; “where does it end?” The biggest battle arena by far is oncology. ” The U.S.

Pharma 210

Pharma Food and Drug Administration Marketing Prescription 210

Pharmaceutical Technology

MAY 11, 2023

In 2016, BioNTech and Genentech, a part of Roche signed an agreement to develop personalised mRNA therapies in oncology. Autogene cevumeran is the lead candidate to come from this collaboration and is being evaluated in different solid tumours. A global randomised follow-up trial is planned.

Patients 138

Patients Leads 138

European Pharmaceutical Review

JULY 11, 2024

He has the right vision, skills and experience to lead our R&D organisation,” commented Rob Michael, Chief Executive Officer, AbbVie. He joined AbbVie in 2016 and was appointed as chief scientific officer in 2019.

Medicine 105

Medicine Medical Leads Training 105

Pharmaceutical Technology

NOVEMBER 21, 2022

According to the report, five member companies decided to decrease their investment in Japan between 2016 and 2017, four companies changed their investment targets between 2018 and 2020, and one company lowered the priority given to Japan after 2021.

Pharmaceutical 52

Pharmaceutical Leads Marketing Manufacturing 52

European Pharmaceutical Review

MARCH 8, 2023

She founded COMPASS Pathways with her husband George Goldsmith in 2016, having experienced at first hand the challenges in accessing evidence-based and effective mental health care for a family member. Click here to read EPR’s previous ‘ Women Inspiring Pharma’ series.

Leads 52

Leads Pharma Food and Drug Administration Medicine 52

Copyright Clearance Center

MAY 2, 2023

Speakers include Christine Kirkpatrick , Founder, GO FAIR US; Barend Mons , President, CODATA; and Erik Schultes , FAIR Implementation Lead, GO FAIR Foundation.

Government 97

Government Training Management Leads 97

Pharmaceutical Technology

MAY 18, 2023

The EMA set up a task force in 2016 in light of issues concerning medicine availability and supply chain. Shortages can lead to medicine rationing and delay in critical treatments, with a significant impact on patient care.

Medicine 99

Medicine Specialization Networking Patients 99

pharmaphorum

JULY 13, 2022

The alliance sees Bicycle and Genentech collaborate on the discovery and preclinical testing of bicyclic peptides, with the Roche company taking over after a lead drug candidate is selected for further development. Roche isn’t the only big pharma partner Bicycle has attracted for its bicyclic peptide technology.

Leads 105

Leads Manufacturing Pharma 105

Legacy MEDSearch

MARCH 15, 2023

Founded in 2016, LIVMOR developed the Halo+ Atrial Fibrillation (AF) Detection System, the world’s first FDA-cleared prescription wearable for continuous cardiac rhythm monitoring. The acquisition extends HeartBeam’s reach in remote monitoring and detection with full ownership of an existing cutting-edge FDA-cleared product.

Food and Drug Administration 97

Food and Drug Administration FDA Recruitment Physicians 97

Clarify Health

MAY 30, 2023

According to its most recent research brief, “The Kids Are Not Alright: Mental Health Utilization Among Children and Young Adults, 2016-2022,” hospital admissions for mental illnesses rose 124% among children and young adults from 2016 – 2022.

Healthcare 92

Healthcare Healthcare Education Transportation 92

European Pharmaceutical Review

JANUARY 9, 2024

The development of AI in and its application to the production process are all going to lead us into a new era where drugs are safer, more effective, and focused on treating patients. 2016; 85(4):2048-2050. 2016; 12(7):878. One of its most useful aspects is that answers to many questions come readily from data analysis.

Pharmaceutical manufacturing 122

Pharmaceutical manufacturing Manufacturing Pharmaceutical Food and Drug Administration 122

pharmaphorum

NOVEMBER 27, 2022

Why not lead?” Let’s lead by doing things – by making decisions to lead.” The Scottish Government has told parliament it will provide further details on how it is transforming genomics in Scotland by the end of this year and will publish a genomics strategy next year. Why do we always have to follow?

Patients 104

Patients Medicine Government Leads 104

World of DTC Marketing

JUNE 4, 2021

Mike always battled weight issues, but since he went out on disability, he had gained more weight, leading to diabetes. An unhealthy diet is one of the leading risk factors for poor health and accounts for up to 45% of all deaths from these cardiometabolic diseases, the researchers noted. Dr. Natalie A. Why are we getting so obese?

Food 207

Food Insurance Leads Medical 207

pharmaphorum

OCTOBER 28, 2022

Nina Pinwill leads the commercial operations function within the Commercial Medicines Directorate at NHS England. Nina gained her MSc in Health Policy from Imperial College London in May 2016 and is a trustee for the Waldenström’s Macroglobulinemia UK charity. She is an SME in market access, rare disease and biosimilars.

Medicine 122

Medicine Management Marketing Leads 122

Pharmaceutical Technology

JUNE 30, 2022

Acoziborole was previously discovered by the company Anacor Pharmaceuticals, which Pfizer acquired in 2016. The post Neglected tropical diseases: non-profits lead the way as private sectors lags appeared first on Pharmaceutical Technology. Sanofi is also developing its Phase IIb/Phase III treatment acoziborole for the same indication.

Leads 64

Leads Pharma Medicine FDA 64

Pharmaceutical Technology

APRIL 4, 2023

AD is the leading cause of dementia, which is an umbrella term for a series of syndromes that can lead to memory loss, cognitive decay, and behavioural change. This was the greatest number of designations awarded in the last ten years and was 40% greater than the previous peak of five designations in 2016.

FDA 98

FDA Specialization Leads Marketing 98

European Pharmaceutical Review

JULY 4, 2022

This strategic investment completes our offering in drug product and strengthens our position as a leading [contract development and manufacturing organisation] CDMO with an unparalleled breadth of offerings across scales and technologies,” commented Pierre-Alain Ruffieux, CEO, Lonza. .

Manufacturing 97

Manufacturing Marketing Leads Pharmaceutical 97

Spotio

MAY 10, 2023

Business-to-business (B2B) prospecting is the pillar of lead generation. According to Technology Advice , 70% of marketers at B2B companies reported that “improving lead quality” was the primary concern. Also, 54%said getting more leads was a top objective as well. Also, 54%said getting more leads was a top objective as well.

B2B Sales 98

B2B Sales Prospecting Sales CRM 98

PM360

OCTOBER 25, 2023

It is the responsibility of state regulators to maximize the number of people in their state who benefit from this without waiting or expecting federal rescheduling to fix everything. What’s Next if Rescheduling is Approved? If rescheduling survives all these hurdles, there are still some major unknowns.

Food and Drug Administration 119

Food and Drug Administration FDA Medical Insurance 119

pharmaphorum

SEPTEMBER 14, 2022

Baumann has been at the helm of Bayer since May 2016, when he took over from Marijn Dekkers, and has spent his entire career at Bayer, rising through the ranks of the company. Bayer has declined to comment on the rumours.

Pharma 98

Pharma Management Leads Marketing 98

European Pharmaceutical Review

AUGUST 26, 2022

Moderna has filed patent infringement lawsuits alleging that Pfizer and BioNTech’s COVID-19 vaccine Comirnaty ® infringes patents Moderna filed between 2010 and 2016 covering its foundational messenger RNA (mRNA) technology. ” But why sue now?

Sales 98

Sales Medicine Marketing Government 98

pharmaphorum

JANUARY 29, 2023

Secondly, pressure on healthcare spending is leading to greater consolidation. Mergers and acquisitions are contributing to consolidation, with about 2,600 healthcare deals globally in 2022, up from 1,500 in 2016. Moreover, new types of investors are emerging that have not traditionally invested in healthcare in the past.

Healthcare 98

Healthcare Healthcare Manufacturing Marketing 98

Legacy MEDSearch

NOVEMBER 28, 2022

Trauma/ER: The BodyTom 64’s unique combination of internal lead shielding and battery operation allows any standard trauma bay to be transformed into an advanced CT imaging suite. The BodyTom 64 brings the power of innovative imaging to patients’ bedsides safely and efficiently. About NeuroLogica. NeuroLogica Corp.,

FDA 92

FDA Food and Drug Administration Electronics Recruitment 92

Clarivate

JANUARY 3, 2023

Starting with 12,160 Research Fronts, representing papers published and cited between 2016 and 2021, the next step was to select the fronts containing core literature that is both highly cited and recent – an indicator of particularly active and fast-moving research. Fields and nations.

Specialization 98

Specialization Side effects Management Medicine 98

European Pharmaceutical Review

DECEMBER 14, 2023

Our research showed that in Europe between 1999 and 2016, 35 products were withdrawn. Samantha leads study design and statistical analysis and has experience with the CPRD electronic health records database. 1,2 This signals a promising trend towards a more comprehensive and diversified approach in regulatory decision-making.

Medicine 116

Medicine Safety Competition Medical 116

European Pharmaceutical Review

OCTOBER 27, 2023

If achieved, this would boost the UK’s competitiveness as a leading international site for trials. This is according to a 2016 paper published in Clinical and Translational Oncology. Timeframes to set up trials were reduced (on average) by 15 percent within a year of the legislation coming into force.”

Ethics 105

Ethics Medicine Education Competition 105

pharmaphorum

DECEMBER 2, 2022

Protocol design factors leading to operational challenges include design consistency, patient burden, site burden, study complexity, and eligibility criteria, including diversity and inclusion requirements. These potential study risks can lead to costly deviations and amendments, enrolment difficulties, and reduced patient compliance.

Competition 98

Competition Leads Patients Electronics 98

pharmaphorum

NOVEMBER 6, 2017

The Cancer Vanguard is a bold initiative setup to take leadership in the delivery of the National Cancer Strategy – Achieving World-Class Cancer Outcomes published in 2015 with a key aim of designing and implementing new and increasingly patient centric models of care in Cancer that can benefit and be adopted by the wider national cancer system.

Medicine 52

Medicine Pharma Patients Leads 52

Curzon Consulting

OCTOBER 17, 2024

Introduced in 2016, the competition enables AMBS MBA students to showcase their skills, innovative thinking, and problem-solving abilities. 17th October 2024 2 Minutes Curzon Consulting is thrilled to sponsor this year’s Alliance Manchester Business School Consultancy Case Competition.

Competition 52

Competition Consulting Recruitment Government 52

European Pharmaceutical Review

DECEMBER 23, 2022

She has over 10 years’ experience of senior management in the medicines manufacturing sector leading integration of complex research projects at the industry-academic interface, driving the sector towards a future workforce and leading and managing large and complex teams across international sites to effectively deliver major flagship initiatives.

Manufacturing 98

Manufacturing Management Pharma Engineering 98

European Pharmaceutical Review

JUNE 29, 2022

consuming, often leading to lengthy additional investigations, cannot detect all types of viruses, and are dependent on various factors like the animal type or the cell model. This could lead to false positives or, even worse, false negatives! London: European Medicines Agency; 2016 [cited May 2022]. These tests are time?consuming,

Ethics 98

Ethics Safety Manufacturing Medicine 98

European Pharmaceutical Review

AUGUST 17, 2022

Despite this toll, AMR has often been called the ‘silent pandemic’: 4 “AMR is sadly silent because it has not been discussed like other pandemics – and of course has been in the shadow of the COVID-19 pandemic in recent years,” commented Melissa Gong Mitchell, Secretariat Lead of the AMR Industry Alliance.

Manufacturing 98

Manufacturing Food and Drug Administration Management Pharmaceutical 98

Pharmaceutical Technology

MARCH 24, 2023

However, it has taken over six years for Amjevita to launch, after first being FDA-approved in 2016. Many other biosimilars have also been FDA-approved since 2016. In addition, two more Humira biosimilars are currently under FDA review and both are anticipated to launch in 2023.

Competition 59

Competition Marketing FDA Physicians 59

PM360

OCTOBER 25, 2023

Between May 1, 2016, and May 31, 2021, 42% of all U.S. When 1+1 ≠ 2 In theory, combining two or more branded agents can lead to a price that exceeds SoC monotherapy. Cancer Drug Approvals That Displaced Existing Standard-of-Care Therapies, 2016–2021.” References: 1. Benjamin, Alexander Xu, Mark P. Lythgoe, and Vinay Prasad.

Food and Drug Administration 105

Food and Drug Administration Manufacturing Marketing Pharmaceutical manufacturing 105

Pharmaceutical Technology

SEPTEMBER 5, 2022

On 23 August, at a Reuters Newsmakers online forum, Soriot announced his interest in increasing AstraZeneca’s portfolio of bolt-on acquisitions leading up to 2025. Between 1 May 2016 and 31 May 2021, the FDA approved 207 drugs for cancer and malignant haematology.

FDA 114

FDA Pharmaceutical Biopharma Pharma 114

pharmaphorum

JULY 27, 2022

These values have seen a year-on-year decline since 2016 for exports and 2015 for imports, in contrast with a general upward trend seen in most comparator countries, said the ABPI. In 2020, exports were valued at $25.9bn, placing the UK ninth out of 20 countries, and imports at $26.8bn, meaning a ranking of tenth out of 20. R&D success.

Government 98

Government Recruitment Medicine Patients 98